The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 4, 2007, Pages 276-280

  Ozdogu, Hakan ^a   Boga, Can ^a   Sozer, Oktay ^a   Sezgin, Nurzen ^a   Kizilkilic, Ebru ^a   Maytalman, Erkan ^a   Yalcintas, Defne ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Flow cytometry; Nitric oxide; Polymorphonuclear leukocytes; Sickle cell disease

Indexed keywords

LIPOCORTIN 5; NITRIC OXIDE;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANNEXINS; APOPTOSIS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; THROMBOSIS;

EID: 34250878355     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20160     Document Type: Article

References (22)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-769.
2. Saunthararajah Y, Vichinsky PE, Embury HS. Sickle cell disease. In: Hoffman R, Benz JE Jr, Shattil JS, Furie B, Cohen JH, Silberstein EL, McGlave P, editors. Hematology: Basic Principles and Practice, 4th ed. Philadelphia: Elsevier; 2005. pp 605-644.
3. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation 2004;11:129-151.
4. Fadlon E, Vordermeier S, Pearson TC, Mire-Sluis AR, Dumonde DC, Phillips J, Fishlock K, Brown KA. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 1998;91:266-274.
5. Celi A, Lorenzet R, Furie B, Furie BC. Platelet-leukocyte-endothelial cell interaction on the blood vessel wall. Semin Hematol 1997;34:327-335.
6. Secco DD, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha Fde Q. Neutrophil migration in inflammation: Nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 2003;9:153-164.
7. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989;83:865-875.
8. Niwa M, Hara A, Kanamori Y, Matsuno H, Kozawa O, Yoshimi N, Mori H, Uematsu T. Inhibition of tumor necrosis factor-α induced neutrophil apoptosis by cyclic AMP: Involvement of caspase cascade. Eur J Pharmacol 1999;371:59-67.
9. Sulowska Z, Majewska E, Klink M, Banasik M, Tchorzewski H. Flow cytometric evaluation of human neutrophil apoptosis during nitric oxide generation in vitro: The role of exogenous antioxidants. Mediators Inflamm 2005;2:81-87.
10. Misso NL, Peacock CD, Watkins DN, Thompson PJ. Nitrite generation and antioxidant effects during neutrophil apoptosis. Free Radic Biol Med 2000;28:934-943.
11. Blaylock MG, Cuthbertson BH, Galley HF, Ferguson NR, Webster NR. The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Radic Biol Med 1998;25:748-752.
12. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1992;1133:275-285.
13. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
14. Arruda MA, Rossi AG, de Freitas MS, Barja-Fidalgo C, Graca-Souza AV. Heme inhibits human neutrophil apoptosis: Involvement of phosphoinositide 3-kinase, MAPK, and NF-κB. J Immunol 2004;173:2023-2030.
15. Eppihimer MJ, Granger DN. Ischemia/reperfusion-induced leukocyte-endothelial interactions in postcapillary venules. Shock 1997;8: 16-25.
16. Makis AC, Hatzimichael EC, Bourantas KL. The role of cytokines in sickle cell disease. Ann Hematol 2000;79:407-413.
17. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Cancer and the immune system. In: Goldsby RA, Kindt TJ, Osborne BA, Kuby J, editors. Immunology, 2nd ed. New York: WH Freeman; 2003. pp 499-547.
18. Skoberne M, Somersan S, Almodovar W, Truong T, Petrova K, Henson PM, Bhardwaj N. The apoptotic cell receptor CR3, but not αvβ5, is a regulator of human dendritic cell immunostimulatory function. Blood 2006;108:947-955.
19. Hofman P. Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process. Curr Drug Targets Inflamm Allergy 2004;3:1-9.
20. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54:283-288.
21. Dunican AL, Leuenroth SJ, Grutkoski P, Ayala A, Simms HH. TNFα-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock 2000;14:284-284.
22. Biffl WL, Moore EE, Moore FA, Barnett CC Jr. Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J Leukoc Biol 1995;58:582-584.